PCM
CORZ icon

Pentwater Capital Management’s Core Scientific CORZ Stock Holding History

Pentwater Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
536,594
-24,315,406
-98% -$572M 0.08% 55
2026
Q1 		$372M Sell
24,852,000
-763,000
-3% -$13M 1.93% 12
2025
Q4 		$373M Buy
25,615,000
+1,365,000
+6% +$23.8M 1.96% 14
2025
Q3 		$435M Buy
24,250,000
+22,385,000
+1,200% +$328M 2.43% 13
2025
Q2 		$31.8M Buy
+1,865,000
New +$18.7M 0.21% 55

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Pentwater Capital Management's CORZ Position: Q2 2026 in Review

Pentwater Capital Management reduced its Core Scientific (CORZ) stake by 98% in Q2 2026, selling an estimated $572M and leaving 536,594 shares worth $13.7M. The position accounts for 0.08% of the portfolio, ranked #55.

Pentwater Capital Management first reported a position in CORZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $435M in Q3 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Pentwater Capital Management held 536,594 shares of Core Scientific worth $13.7M as of Q2 2026.
  • Pentwater Capital Management sold 24,315,406 Core Scientific shares in Q2 2026, an estimated $572M.
  • Core Scientific made up 0.08% of Pentwater Capital Management's portfolio in Q2 2026, its #55 holding.
  • Pentwater Capital Management first reported a position in Core Scientific in Q2 2025 and has held it in 5 quarters since.
  • Pentwater Capital Management's Core Scientific position peaked at $435M in Q3 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.